Showing results (2791-2800 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|February 22, 2005
Soluble adhesion molecules in the pathogenesis of rheumatoid arthritisMichael V VolinCurrent Pharmaceutical Design|February 22, 2005
A role for the complement system in rheumatoid arthritisJ M Low, T L MooreCurrent Pharmaceutical Design|February 24, 2005
Fibrosis as a therapeutic target post-myocardial infarctionFiona See, Andrew Kompa, Jennifer Martin, et al.Current Pharmaceutical Design|February 24, 2005
The diagnostic and prognostic value of brain natriuretic peptide and aminoterminal (nt)-pro brain natriuretic peptideThomas Weber, Johann Auer, Bernd EberCurrent Pharmaceutical Design|February 24, 2005
Ximelagatran--a promising new drug in thromboembolic disordersPalle PetersenCurrent Pharmaceutical Design|February 3, 2004
Targets of antidementive therapy: drugs with a specific pharmacological mechanism of actionLutz Frölich, Johannes Fox, Frank Padberg, et al.Current Pharmaceutical Design|February 3, 2004
Development and engineering of lymphatic endothelial cells: clinical implicationsJörg Wilting, Lothar SchweigererCurrent Pharmaceutical Design|February 5, 2004
Modulation of PMN-endothelial cells interactions by cyclic nucleotidesYukio SatoCurrent Pharmaceutical Design|August 24, 2004
Osteoblast differentiation and control by vitamin D and vitamin D metabolitesM van Driel, H A P Pols, J P T M van LeeuwenCurrent Pharmaceutical Design|August 24, 2004
Growth factors and bone formation in osteoporosis: roles for fibroblast growth factor and transforming growth factor betaOlivia Fromigué, Dominique Modrowski, Pierre J MariePageof 1,008